Skip to main content
. 2017 Jan 31;8(9):15632–15641. doi: 10.18632/oncotarget.14921

Table 4. Multivariate analysis for disease-free survival and overall survival.

Variables P value DFSHR (95 % CI) P value OSHR (95 % CI)
Lesion (peripheral vs central) 0.427 1.114(0.854 – 1.452) 0.390 1.125(0.861 – 1.470)
Pathological stage (I, II, IIIA) <0.001 1.794(1.563 –2.059) <0.001 1.830(1.594– 2.101)
Resection type (pneumonectomy, lobectomy) 0.435 1.147(0.813 – 1.620) 0.592 1.100(0.777– 1.556)
RDW (≥13.0 vs <13.0 %) 0.019 1.317(1.046 – 1.657) 0.009 1.360(1.081– 1.712)
Albumin (>40 vs ≤40 gL-1) 0.913 1.015(0.782 – 1.316) 0.899 0.983(0.757 – 1.277)
D-dimer (>0.1vs ≤0.1 mgL-1) 0.371 1.114(0.880– 1.410) 0.720 1.044(0.824– 1.322)
ALP (≥71vs <71UL-1) 0.747 1.040(0.820– 1.319) 0.857 1.022(0.806 – 1.296)
Fibrinogen (≥3.543vs <3.543gL-1) 0.225 1.164(0.910– 1.490) 0.114 1.217(0.954– 1.554)
COP-MPV (0,1,2) <0.001 1.719(1.454– 2.033) <0.001 1.775(1.500 – 2.101)

Abbreviations: DFS, disease-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; RDW, red blood cell distribution width; ALP, alkaline phosphatase; COP-MPV, combination of preoperative platelet count and mean platelet volume.

P less than .05 is statistically significant.